Cocrystal Pharma
Stock Forecast, Prediction & Price Target

Cocrystal Pharma Financial Estimates

Cocrystal Pharma Revenue Estimates

Cocrystal Pharma EBITDA Estimates

Cocrystal Pharma Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $2M
Low: $2M
High: $2M
avg. 0%
Avg: $0
Low: $0
High: $0
avg. -100%
Net Income
 
% change YoY
$-14.18M
 
N/A
$-38.84M
 
-173.76%
$-17.98M
 
53.70%
Avg: $-23.95M
Low: $-23.54M
High: $-15.82M
avg. -33.17%
Avg: $-26.3M
Low: $-24.89M
High: $-24.89M
avg. -9.81%
EBITDA
 
% change YoY
$-14.03M
 
N/A
$-17.74M
 
-26.49%
$-19.37M
 
-9.14%
Avg: $665.63K
Low: $665.63K
High: $665.63K
avg. 103.43%
Avg: $0
Low: $0
High: $0
avg. -100%
EPS
 
% change YoY
-$0.16
 
N/A
-$4.77
 
-2881.24%
-$0
 
99.96%
Avg: -$1.98
Low: -$2.44
High: -$1.64
avg. -104110.52%
Avg: -$2.58
Low: -$2.58
High: -$2.58
avg. -30.30%
Operating Expenses
 
% change YoY
$14.22M
 
N/A
$18.13M
 
27.53%
$22.54M
 
24.31%
Avg: $2.54M
Low: $2.54M
High: $2.54M
avg. -88.70%
Avg: $0
Low: $0
High: $0
avg. -100%

FAQ

What is Cocrystal Pharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -21.49% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is -23.54M, average is -23.95M and high is -15.82M.

What is Cocrystal Pharma stock revenue growth forecast?

We have gathered data from 1 analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.

What is Cocrystal Pharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -52070.41% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.44, average is -$1.98 and high is $-1.64.